Future research in ITP: An ICIS consensus

James L. Zehnder, John W. Semple, Paul Imbach, Ellis J. Neufeld, George R. Buchanan, Douglas B. Cines

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.

Original languageEnglish (US)
Pages (from-to)S19-S23
JournalAnnals of Hematology
Volume89
Issue numberSUPPL. 1
DOIs
StatePublished - Jul 1 2010

Keywords

  • Autoimmune diseases
  • ITP
  • Immune thrombocytopenia

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Future research in ITP: An ICIS consensus'. Together they form a unique fingerprint.

  • Cite this

    Zehnder, J. L., Semple, J. W., Imbach, P., Neufeld, E. J., Buchanan, G. R., & Cines, D. B. (2010). Future research in ITP: An ICIS consensus. Annals of Hematology, 89(SUPPL. 1), S19-S23. https://doi.org/10.1007/s00277-010-0917-1